Journal article
Structural basis of biased T cell receptor recognition of an immunodominant HLA-A2 epitope of the SARS-CoV-2 spike protein
P Chaurasia, THO Nguyen, LC Rowntree, JA Juno, AK Wheatley, SJ Kent, K Kedzierska, J Rossjohn, J Petersen
Journal of Biological Chemistry | ELSEVIER | Published : 2021
Abstract
CD8+ T cells play an important role in vaccination and immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Although numerous SARS-CoV-2 CD8+ T cell epitopes have been identified, the molecular basis underpinning T cell receptor (TCR) recognition of SARS-CoV-2-specific T cells remains unknown. The T cell response directed toward SARS-CoV-2 spike protein-derived S269-277 peptide presented by the human leukocyte antigen (HLA)A*02:01 allomorph (hereafter the HLA-A2S269-277 epitope) is, to date, the most immunodominant SARS-CoV-2 epitope found in individuals bearing this allele. As HLA-A2S269-277 - specific CD8+ T cells utilize biased TRAV12 gene usage within ..
View full abstractRelated Projects (2)
Grants
Awarded by Australian Research Council
Funding Acknowledgements
This work was supported by the NHMRC Leadership Investigator Grant to K. K. (1173871), NHMRC Emerging Leadership Level 1 Investigator Grant to T. H. O. N. (#1194036), Research Grants Council of the Hong Kong Special Administrative Region, China (#T11-712/19-N) to K. K., and MRFF Award (#2005544) to K. K., S. J. K., A. K. W., and J. A. J. A. K. W. are supported by Emerging Leadership 1 Investigator Grant (#1173433), J. A. J. by an NHMRC Early Career Fellowship (ECF) (#1123673), and S. J. K. by NHMRC Senior Principal Research Fellowship (#1136322). J. R. is supported by an ARC Laureate fellowship.